Sign Up Today and Learn More About Cerebral Stock
Invest in or calculate the value of your shares in Cerebral or other pre-IPO companies through EquityZen's platform.

Cerebral Stock (CERE)
Mental Health Telemedicine
Cerebral develops an online mental healthcare platform
About Cerebral Stock
Founded
2020
Headquarters
San Francisco, CA, US
Total Funding
462M
Industries
Health Care, Mobile
Cerebral is a mental health telemedicine company. Cerebral offers therapy and medication for patients with mental illnesses such as anxiety or depression. Cerebral claims to offer its platform to individuals, employers, and payers.
Cerebral was founded in 2020 and is headquartered in San Francisco, California. Notable investors include SoftBank Vision Fund, WestCap, and Access Industries.
Cerebral Press Mentions
Stay in the know about the latest news on Cerebral
Cerebral CEO Steps Down, Founds New Behavioral Health Triage Venture
bhbusiness • Mar 05, 2025
Cerebral's former CEO just raised seed funding from Morningside for a new mental health startup
businessinsider • Mar 04, 2025
Cerebral CEO David Mou has stepped down
endpts • Mar 04, 2025
Top Growth Driver In The Online Psychology Counseling Market 2025: Increasing Prevalence Of Mental Health Disorders
einpresswire • Mar 01, 2025
Hundreds Of Unicorns Haven’t Raised New Funding Since 2021
medium • Feb 15, 2025
Investors in Cerebral
Discover investors in Cerebral stock and explore their portfolio companies
Cerebral Management
Leadership team at Cerebral
Chief Executive Officer
Kyle Robertson
Chief Financial Officer
Meg Miller McKenna

Join now and verify your accreditation status to gain access to:
- Cerebral Current Valuation
- Cerebral Stock Price
- Cerebral Management
- Available deals in Cerebral and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Cerebral Cap Table and Funding History by Share Class and Liquidity Preferences
- Cerebral Revenue and Financials
- Cerebral Highlights
- Cerebral Business Model
- Cerebral Risk Factors
- Cerebral Research Report from SACRA Research
Trading Cerebral Stock
How to invest in Cerebral stock?
Accredited investors can buy pre-IPO stock in companies like Cerebral through EquityZen funds. These investments are made available by existing Cerebral shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Cerebral stock?
Shareholders can sell their Cerebral stock through EquityZen's private company marketplace. EquityZen's network includes over 350K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 45K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."